| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Software | 9 | 2014 | 1321 | 1.250 |
Why?
|
| Sequence Analysis, DNA | 14 | 2015 | 2483 | 1.000 |
Why?
|
| Genomics | 6 | 2015 | 2738 | 0.620 |
Why?
|
| Genome, Human | 15 | 2013 | 1869 | 0.570 |
Why?
|
| DNA | 4 | 2014 | 2693 | 0.530 |
Why?
|
| Computational Biology | 6 | 2014 | 1271 | 0.510 |
Why?
|
| Algorithms | 7 | 2013 | 3890 | 0.500 |
Why?
|
| Chromosome Breakpoints | 2 | 2013 | 104 | 0.490 |
Why?
|
| Genome Components | 1 | 2013 | 4 | 0.490 |
Why?
|
| High-Throughput Nucleotide Sequencing | 6 | 2015 | 2291 | 0.480 |
Why?
|
| Human Genome Project | 1 | 2013 | 64 | 0.470 |
Why?
|
| DNA, Neoplasm | 5 | 2015 | 1910 | 0.460 |
Why?
|
| Oncogene Fusion | 1 | 2013 | 63 | 0.460 |
Why?
|
| Genomic Structural Variation | 1 | 2013 | 77 | 0.450 |
Why?
|
| Sequence Deletion | 5 | 2014 | 875 | 0.450 |
Why?
|
| Glioblastoma | 3 | 2013 | 1797 | 0.420 |
Why?
|
| Oncogene Proteins, Fusion | 4 | 2013 | 755 | 0.420 |
Why?
|
| Databases, Genetic | 4 | 2013 | 745 | 0.420 |
Why?
|
| Sequence Alignment | 5 | 2014 | 844 | 0.370 |
Why?
|
| Polymorphism, Single Nucleotide | 10 | 2015 | 4549 | 0.330 |
Why?
|
| Sequence Analysis, RNA | 1 | 2012 | 651 | 0.330 |
Why?
|
| Mutation, Missense | 1 | 2013 | 1152 | 0.320 |
Why?
|
| Mutation | 15 | 2015 | 15179 | 0.310 |
Why?
|
| Cell Transformation, Neoplastic | 2 | 2013 | 2359 | 0.300 |
Why?
|
| Clonal Evolution | 3 | 2014 | 253 | 0.290 |
Why?
|
| Neoplasms | 7 | 2015 | 15193 | 0.250 |
Why?
|
| Gene Dosage | 4 | 2013 | 829 | 0.250 |
Why?
|
| Transcriptome | 1 | 2012 | 1859 | 0.230 |
Why?
|
| Genetic Variation | 3 | 2014 | 2086 | 0.220 |
Why?
|
| Leukemia, Myeloid, Acute | 8 | 2013 | 6915 | 0.200 |
Why?
|
| Clone Cells | 4 | 2014 | 555 | 0.180 |
Why?
|
| Breast Neoplasms | 6 | 2015 | 15694 | 0.170 |
Why?
|
| Genome | 2 | 2014 | 672 | 0.170 |
Why?
|
| Ovarian Neoplasms | 2 | 2013 | 4638 | 0.160 |
Why?
|
| Leukemia, Promyelocytic, Acute | 2 | 2011 | 430 | 0.150 |
Why?
|
| Gene Expression Regulation, Neoplastic | 3 | 2008 | 8873 | 0.140 |
Why?
|
| Protein Structure, Tertiary | 3 | 2008 | 1487 | 0.140 |
Why?
|
| Sensitivity and Specificity | 2 | 2015 | 4971 | 0.130 |
Why?
|
| src Homology Domains | 2 | 2006 | 124 | 0.130 |
Why?
|
| Brain Neoplasms | 2 | 2010 | 4849 | 0.130 |
Why?
|
| Humans | 34 | 2015 | 261506 | 0.130 |
Why?
|
| Point Mutation | 3 | 2012 | 769 | 0.120 |
Why?
|
| Likelihood Functions | 1 | 2014 | 233 | 0.120 |
Why?
|
| Drugs, Investigational | 1 | 2015 | 135 | 0.120 |
Why?
|
| Chromosome Inversion | 1 | 2014 | 182 | 0.120 |
Why?
|
| Chromosome Duplication | 1 | 2014 | 157 | 0.120 |
Why?
|
| Base Sequence | 3 | 2011 | 4917 | 0.120 |
Why?
|
| Atlases as Topic | 1 | 2013 | 42 | 0.120 |
Why?
|
| Chromosome Breakage | 1 | 2013 | 226 | 0.110 |
Why?
|
| Molecular Sequence Annotation | 1 | 2013 | 201 | 0.110 |
Why?
|
| Aromatase | 1 | 2012 | 56 | 0.110 |
Why?
|
| Biomarkers, Tumor | 4 | 2015 | 10331 | 0.110 |
Why?
|
| Gene Fusion | 4 | 2015 | 209 | 0.100 |
Why?
|
| Tumor Suppressor Proteins | 2 | 2011 | 1823 | 0.100 |
Why?
|
| Proto-Oncogene Proteins c-met | 1 | 2015 | 419 | 0.100 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2014 | 332 | 0.100 |
Why?
|
| Cell Line, Tumor | 4 | 2015 | 14551 | 0.100 |
Why?
|
| Molecular Sequence Data | 5 | 2012 | 6089 | 0.090 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2012 | 203 | 0.090 |
Why?
|
| Aromatase Inhibitors | 1 | 2012 | 305 | 0.090 |
Why?
|
| Receptors, Retinoic Acid | 1 | 2011 | 365 | 0.090 |
Why?
|
| Decision Support Techniques | 1 | 2015 | 622 | 0.090 |
Why?
|
| Adenocarcinoma, Bronchiolo-Alveolar | 1 | 2008 | 74 | 0.080 |
Why?
|
| Genetics, Population | 1 | 2009 | 242 | 0.080 |
Why?
|
| Genes, erbB-1 | 1 | 2008 | 101 | 0.080 |
Why?
|
| Alleles | 1 | 2014 | 2437 | 0.080 |
Why?
|
| Neurofibromin 1 | 1 | 2008 | 85 | 0.080 |
Why?
|
| DNA Modification Methylases | 1 | 2008 | 172 | 0.080 |
Why?
|
| Bone Marrow Cells | 1 | 2012 | 943 | 0.080 |
Why?
|
| Genes, Tumor Suppressor | 2 | 2008 | 1064 | 0.080 |
Why?
|
| Precision Medicine | 1 | 2015 | 1154 | 0.080 |
Why?
|
| DNA Repair Enzymes | 1 | 2008 | 237 | 0.070 |
Why?
|
| Pattern Recognition, Automated | 1 | 2007 | 125 | 0.070 |
Why?
|
| Protein Interaction Mapping | 1 | 2007 | 162 | 0.070 |
Why?
|
| Neoplasm Transplantation | 1 | 2010 | 1519 | 0.070 |
Why?
|
| Genes, p53 | 1 | 2011 | 1090 | 0.070 |
Why?
|
| Models, Molecular | 2 | 2008 | 1732 | 0.070 |
Why?
|
| Quantitative Structure-Activity Relationship | 1 | 2006 | 30 | 0.070 |
Why?
|
| Female | 14 | 2015 | 141928 | 0.070 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 2 | 2014 | 5319 | 0.070 |
Why?
|
| Proto-Oncogene Proteins c-abl | 1 | 2006 | 79 | 0.070 |
Why?
|
| Lung Neoplasms | 3 | 2014 | 11538 | 0.070 |
Why?
|
| Isocitrate Dehydrogenase | 1 | 2009 | 480 | 0.060 |
Why?
|
| DNA Mutational Analysis | 4 | 2012 | 2283 | 0.060 |
Why?
|
| DNA Repair | 2 | 2012 | 1872 | 0.060 |
Why?
|
| Gene Frequency | 3 | 2015 | 1163 | 0.060 |
Why?
|
| Computer Simulation | 1 | 2009 | 1529 | 0.060 |
Why?
|
| Smoking | 1 | 2012 | 2440 | 0.060 |
Why?
|
| Peptides | 2 | 2006 | 1479 | 0.060 |
Why?
|
| Amino Acid Sequence | 4 | 2012 | 4233 | 0.050 |
Why?
|
| DNA Methylation | 2 | 2013 | 2669 | 0.050 |
Why?
|
| DNA Copy Number Variations | 3 | 2015 | 1516 | 0.050 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2008 | 1678 | 0.050 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2015 | 5539 | 0.050 |
Why?
|
| Mutagenesis, Insertional | 2 | 2015 | 218 | 0.050 |
Why?
|
| Skin | 3 | 2012 | 1259 | 0.050 |
Why?
|
| Mice, SCID | 2 | 2015 | 1869 | 0.050 |
Why?
|
| Adult | 9 | 2014 | 77950 | 0.050 |
Why?
|
| Genomic Instability | 2 | 2013 | 519 | 0.040 |
Why?
|
| Nuclear Proteins | 1 | 2011 | 3343 | 0.040 |
Why?
|
| Gene Expression Profiling | 4 | 2015 | 5159 | 0.040 |
Why?
|
| Disease Progression | 4 | 2012 | 6682 | 0.040 |
Why?
|
| Molecular Targeted Therapy | 3 | 2015 | 2330 | 0.040 |
Why?
|
| Proteins | 1 | 2007 | 1963 | 0.040 |
Why?
|
| Myelodysplastic Syndromes | 1 | 2012 | 2979 | 0.040 |
Why?
|
| Recurrence | 3 | 2012 | 4758 | 0.040 |
Why?
|
| Gene Deletion | 2 | 2015 | 1442 | 0.040 |
Why?
|
| Nerve Tissue Proteins | 1 | 2006 | 1491 | 0.040 |
Why?
|
| Middle Aged | 7 | 2015 | 86204 | 0.040 |
Why?
|
| Antineoplastic Agents | 3 | 2015 | 14289 | 0.040 |
Why?
|
| Transcription Factors | 1 | 2011 | 5270 | 0.040 |
Why?
|
| Databases, Protein | 2 | 2007 | 100 | 0.040 |
Why?
|
| Animals | 7 | 2015 | 59536 | 0.040 |
Why?
|
| Amino Acid Motifs | 2 | 2007 | 392 | 0.030 |
Why?
|
| Reproducibility of Results | 3 | 2012 | 6009 | 0.030 |
Why?
|
| Translocation, Genetic | 2 | 2012 | 1245 | 0.030 |
Why?
|
| Male | 8 | 2014 | 123000 | 0.030 |
Why?
|
| Oxygenases | 1 | 2014 | 26 | 0.030 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2012 | 2508 | 0.030 |
Why?
|
| DNA Fingerprinting | 1 | 2014 | 167 | 0.030 |
Why?
|
| Genome-Wide Association Study | 2 | 2012 | 2265 | 0.030 |
Why?
|
| Drug Approval | 1 | 2015 | 178 | 0.030 |
Why?
|
| United States Food and Drug Administration | 1 | 2015 | 332 | 0.030 |
Why?
|
| Protein Conformation | 2 | 2007 | 1258 | 0.030 |
Why?
|
| Aged, 80 and over | 2 | 2014 | 29902 | 0.030 |
Why?
|
| Ligands | 2 | 2006 | 995 | 0.030 |
Why?
|
| Guided Tissue Regeneration | 1 | 2012 | 7 | 0.030 |
Why?
|
| MAP Kinase Kinase Kinase 1 | 1 | 2012 | 43 | 0.030 |
Why?
|
| Cyclin-Dependent Kinase 4 | 1 | 2013 | 198 | 0.030 |
Why?
|
| INDEL Mutation | 1 | 2012 | 112 | 0.030 |
Why?
|
| Heterografts | 1 | 2014 | 733 | 0.030 |
Why?
|
| MAP Kinase Kinase 4 | 1 | 2012 | 142 | 0.030 |
Why?
|
| Regenerative Medicine | 1 | 2012 | 49 | 0.030 |
Why?
|
| Base Pairing | 1 | 2012 | 68 | 0.030 |
Why?
|
| Adolescent | 2 | 2012 | 31252 | 0.030 |
Why?
|
| Mice | 4 | 2014 | 34495 | 0.030 |
Why?
|
| Epigenomics | 1 | 2013 | 266 | 0.030 |
Why?
|
| Promyelocytic Leukemia Protein | 1 | 2011 | 55 | 0.030 |
Why?
|
| Retinoic Acid Receptor alpha | 1 | 2011 | 95 | 0.020 |
Why?
|
| Base Pair Mismatch | 1 | 2011 | 78 | 0.020 |
Why?
|
| Androstadienes | 1 | 2012 | 165 | 0.020 |
Why?
|
| Leukemia, Experimental | 1 | 2011 | 78 | 0.020 |
Why?
|
| Gene Library | 1 | 2012 | 294 | 0.020 |
Why?
|
| Mice, 129 Strain | 1 | 2011 | 170 | 0.020 |
Why?
|
| CpG Islands | 1 | 2013 | 633 | 0.020 |
Why?
|
| Single-Cell Analysis | 1 | 2014 | 470 | 0.020 |
Why?
|
| Cell Proliferation | 2 | 2015 | 7226 | 0.020 |
Why?
|
| Aged | 3 | 2014 | 70117 | 0.020 |
Why?
|
| alpha Catenin | 1 | 2010 | 23 | 0.020 |
Why?
|
| Janus Kinase 1 | 1 | 2011 | 121 | 0.020 |
Why?
|
| Genes, Neoplasm | 1 | 2012 | 324 | 0.020 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2013 | 621 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2008 | 11965 | 0.020 |
Why?
|
| Mutagenesis | 1 | 2012 | 483 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 15 | 1 | 2011 | 231 | 0.020 |
Why?
|
| Jumonji Domain-Containing Histone Demethylases | 1 | 2011 | 113 | 0.020 |
Why?
|
| Models, Theoretical | 1 | 2014 | 785 | 0.020 |
Why?
|
| Protein Binding | 2 | 2007 | 3438 | 0.020 |
Why?
|
| Introns | 1 | 2011 | 432 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 1 | 2013 | 507 | 0.020 |
Why?
|
| Germ-Line Mutation | 1 | 2015 | 1046 | 0.020 |
Why?
|
| Transfection | 1 | 2015 | 2944 | 0.020 |
Why?
|
| Gene Duplication | 1 | 2012 | 421 | 0.020 |
Why?
|
| Evidence-Based Medicine | 1 | 2015 | 1085 | 0.020 |
Why?
|
| Gene Rearrangement | 1 | 2013 | 783 | 0.020 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2011 | 997 | 0.020 |
Why?
|
| Amino Acid Substitution | 1 | 2011 | 644 | 0.020 |
Why?
|
| Age of Onset | 1 | 2011 | 827 | 0.020 |
Why?
|
| Tumor Burden | 1 | 2015 | 1987 | 0.020 |
Why?
|
| Exons | 1 | 2012 | 1328 | 0.020 |
Why?
|
| Proto-Oncogenes | 1 | 2008 | 202 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 17 | 1 | 2011 | 641 | 0.020 |
Why?
|
| Structural Homology, Protein | 1 | 2007 | 42 | 0.020 |
Why?
|
| Triazoles | 1 | 2012 | 617 | 0.020 |
Why?
|
| Transplantation, Heterologous | 1 | 2010 | 1082 | 0.020 |
Why?
|
| Nitriles | 1 | 2012 | 906 | 0.020 |
Why?
|
| Sequence Analysis, Protein | 1 | 2007 | 81 | 0.020 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2013 | 1265 | 0.020 |
Why?
|
| Cell Movement | 1 | 2015 | 2466 | 0.020 |
Why?
|
| Neoplasm Invasiveness | 1 | 2015 | 3981 | 0.020 |
Why?
|
| Cystadenocarcinoma, Serous | 1 | 2011 | 486 | 0.020 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2013 | 1439 | 0.020 |
Why?
|
| Exome | 1 | 2012 | 1239 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2015 | 4892 | 0.020 |
Why?
|
| Static Electricity | 1 | 2006 | 58 | 0.020 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2012 | 1242 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2008 | 37905 | 0.020 |
Why?
|
| Structure-Activity Relationship | 1 | 2007 | 931 | 0.020 |
Why?
|
| Chromosome Aberrations | 1 | 2012 | 1960 | 0.020 |
Why?
|
| Terminology as Topic | 1 | 2007 | 414 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2015 | 6207 | 0.020 |
Why?
|
| Carrier Proteins | 1 | 2013 | 2022 | 0.020 |
Why?
|
| Gene Expression | 1 | 2013 | 3570 | 0.020 |
Why?
|
| Receptors, Estrogen | 1 | 2012 | 2086 | 0.020 |
Why?
|
| Forecasting | 1 | 2007 | 694 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2011 | 3639 | 0.020 |
Why?
|
| Triple Negative Breast Neoplasms | 1 | 2014 | 1215 | 0.020 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2007 | 445 | 0.020 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2007 | 621 | 0.010 |
Why?
|
| DNA Damage | 1 | 2012 | 1954 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 2014 | 3719 | 0.010 |
Why?
|
| Young Adult | 2 | 2012 | 21445 | 0.010 |
Why?
|
| Phenotype | 1 | 2015 | 6295 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2013 | 9180 | 0.010 |
Why?
|
| Binding Sites | 1 | 2006 | 2171 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2012 | 4078 | 0.010 |
Why?
|
| Time Factors | 1 | 2015 | 12926 | 0.010 |
Why?
|
| Proteomics | 1 | 2007 | 1380 | 0.010 |
Why?
|
| MicroRNAs | 1 | 2013 | 2947 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2008 | 6100 | 0.010 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2011 | 3552 | 0.010 |
Why?
|
| United States | 1 | 2015 | 15433 | 0.010 |
Why?
|
| Prognosis | 1 | 2015 | 21713 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2012 | 32848 | 0.010 |
Why?
|